D
Cellebrite DI Ltd.
CLBT
$11.05
-$0.22-1.95%
D
Sell
2/2/2024Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 2/2/2024 due to an increase in the total return index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 2/2/2024 due to an increase in the total return index.
D
Sell
1/11/2024Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 1/11/2024 due to a decline in the total return index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 1/11/2024 due to a decline in the total return index.
D
Sell
12/27/2023Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 12/27/2023 due to a significant increase in the efficiency index, total return index and volatility index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 12/27/2023 due to a significant increase in the efficiency index, total return index and volatility index.
D
Sell
9/5/2023Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from C on 9/5/2023 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 557.02% from $7.08M to -$32.35M, debt to equity increased from 0.07 to 0.28, and total capital declined 65.1% from $89.22M to $31.14M.
Cellebrite DI Ltd. (CLBT) was downgraded to D from C on 9/5/2023 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 557.02% from $7.08M to -$32.35M, debt to equity increased from 0.07 to 0.28, and total capital declined 65.1% from $89.22M to $31.14M.
C
Hold
6/8/2023Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to C from C- on 6/8/2023 due to an increase in the total return index and volatility index.
Cellebrite DI Ltd. (CLBT) was upgraded to C from C- on 6/8/2023 due to an increase in the total return index and volatility index.
C
Hold
5/18/2023Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to C- from D+ on 5/18/2023 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 977.56% from -$4.07M to $35.74M, EBIT increased 272.78% from -$5.6M to $9.67M, and total revenue increased 18.29% from $62.57M to $74.02M.
Cellebrite DI Ltd. (CLBT) was upgraded to C- from D+ on 5/18/2023 due to a noticeable increase in the solvency index, growth index and valuation index. Operating cash flow increased 977.56% from -$4.07M to $35.74M, EBIT increased 272.78% from -$5.6M to $9.67M, and total revenue increased 18.29% from $62.57M to $74.02M.
D
Sell
3/16/2023Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 3/16/2023 due to an increase in the volatility index and total return index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 3/16/2023 due to an increase in the volatility index and total return index.
D
Sell
2/27/2023Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 2/27/2023 due to a decline in the valuation index and volatility index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 2/27/2023 due to a decline in the valuation index and volatility index.
D
Sell
2/9/2023Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 2/9/2023 due to an increase in the total return index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 2/9/2023 due to an increase in the total return index.
D
Sell
11/29/2022Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 11/29/2022 due to a decline in the volatility index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 11/29/2022 due to a decline in the volatility index.
D
Sell
11/11/2022Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 11/11/2022 due to an increase in the volatility index and total return index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 11/11/2022 due to an increase in the volatility index and total return index.
D
Sell
10/24/2022Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 10/24/2022 due to a decline in the volatility index, valuation index and total return index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 10/24/2022 due to a decline in the volatility index, valuation index and total return index.
D
Sell
10/6/2022Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 10/6/2022 due to an increase in the valuation index and volatility index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 10/6/2022 due to an increase in the valuation index and volatility index.
D
Sell
9/21/2022Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 9/21/2022 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 230.03% from $4.31M to -$5.6M, operating cash flow declined 113.67% from $29.79M to -$4.07M, and earnings per share declined from $0.2603 to $0.1632.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 9/21/2022 due to a major decline in the growth index, solvency index and volatility index. EBIT declined 230.03% from $4.31M to -$5.6M, operating cash flow declined 113.67% from $29.79M to -$4.07M, and earnings per share declined from $0.2603 to $0.1632.
D
Sell
8/24/2022Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 8/24/2022 due to an increase in the volatility index, valuation index and total return index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 8/24/2022 due to an increase in the volatility index, valuation index and total return index.
D
Sell
8/9/2022Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 8/9/2022 due to a decline in the volatility index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 8/9/2022 due to a decline in the volatility index.
D
Sell
7/20/2022Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 7/20/2022 due to an increase in the volatility index.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 7/20/2022 due to an increase in the volatility index.
D
Sell
7/5/2022Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 7/5/2022 due to a decline in the solvency index, total return index and volatility index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 7/5/2022 due to a decline in the solvency index, total return index and volatility index.
D
Sell
3/31/2022Upgraded
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 3/31/2022 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 565.35% from $7.8M to $51.87M.
Cellebrite DI Ltd. (CLBT) was upgraded to D+ from D on 3/31/2022 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 565.35% from $7.8M to $51.87M.
D
Sell
11/30/2021Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 11/30/2021 due to a large decline in the volatility index and total return index.
Cellebrite DI Ltd. (CLBT) was downgraded to D from D+ on 11/30/2021 due to a large decline in the volatility index and total return index.
D
Sell
11/19/2021Downgrade
Cellebrite DI Ltd. (CLBT) was downgraded to D+ from C- on 11/19/2021 due to a noticeable decline in the volatility index and total return index.
Cellebrite DI Ltd. (CLBT) was downgraded to D+ from C- on 11/19/2021 due to a noticeable decline in the volatility index and total return index.
C
Hold
11/3/2021None
Cellebrite DI Ltd. (CLBT) was downgraded to C- from U on 11/03/2021.
Cellebrite DI Ltd. (CLBT) was downgraded to C- from U on 11/03/2021.
NASDAQ
05/10/2024 4:00PM Eastern
Quotes delayed
